Prevalence and recovery of adrenal insufficiency in steroid-dependent asthma patients receiving biologic therapy.
Amazing work @asthmalondon@GSTTnhs@GrainnedAn@briandkent
https://t.co/Jc0lkFbD2b
Poor adherence to ICS is common in severe asthma patients receiving mepolizumab, and is associated with increased oral corticosteroid exposure and exacerbation risk https://t.co/NgylaP6raj
https://t.co/gXOzCQLUCA Delighted to publish the first data looking at the effect of ICS adherence on outcome with biologics in severe eosinophilic asthma. Answer: keep taking your steroid inhaler on Nucala @briandkent@asthmalondon@LondonLungs@M_FFerreiro@CrisRoxas1
Blockade of interleukin-5 with reslizumab appears to have significant oral corticosteroid sparing effects in patients with eosinophilic granulomatosis with polyangiitis and severe eosinophilic asthma https://t.co/4AMCNXgY2k - great work @briandkent (@GSTTnhs)